Markus Mandler

Vienna, 1030, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

A Case Report of a Novel Alpha-Synuclein Vaccine (TRB-001) in a Parkinson's Patient: Safe Administration and Induction of a High-Titer, High-Avidity Functional Antibody Response.

A Case Report of a Novel Alpha-Synuclein Vaccine (TRB-001) in a Parkinson's Patient: Safe Administration and Induction of a High-Titer, High-Avidity Functional Antibody Response.

Journal: Vaccines

Published: March 31, 2026

WISIT vaccines based on IL-31-derived peptides as a novel therapeutic approach for chronic pruritic dermatoses.

WISIT vaccines based on IL-31-derived peptides as a novel therapeutic approach for chronic pruritic dermatoses.

Journal: PloS one

Published: September 15, 2024

Improved tropoelastin synthesis in the skin by codon optimization and nucleotide modification of tropoelastin-encoding synthetic mRNA.

Improved tropoelastin synthesis in the skin by codon optimization and nucleotide modification of tropoelastin-encoding synthetic mRNA.

Journal: Molecular therapy. Nucleic acids

Published: November 14, 2022

A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice.

A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice.

Journal: Vaccines

Published: July 22, 2022

Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression.

Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression.

Journal: Pharmaceutics

Published: November 16, 2021

Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like model.

Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like model.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: October 24, 2018

Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.

Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.

Journal: Scientific reports

Published: March 14, 2018

Active immunization therapies for Parkinson's disease and multiple system atrophy.

Active immunization therapies for Parkinson's disease and multiple system atrophy.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: June 01, 2015

Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.

Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.

Journal: Journal of neuroinflammation

Published: April 30, 2015

Results from a Phase II Study to Assess the Clinical and Immunological Activity of AFFITOPE® AD02 in Patients with Early Alzheimer's Disease.

Results from a Phase II Study to Assess the Clinical and Immunological Activity of AFFITOPE® AD02 in Patients with Early Alzheimer's Disease.

Journal: The journal of prevention of Alzheimer's disease

Published: January 01, 2015

Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.

Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.

Journal: Molecular neurodegeneration

Published: October 08, 2014

Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccines.

Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccines.

Journal: PloS one

Published: March 14, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026